PepGen Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for PEPG, updated each market day.
PEPG AI Sentiment
AI predicts PepGen Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About PepGen Inc. Common Stock
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
Sector
Exchange
Market Cap
$111,275,620
Cap Tier
Employees
56
Headquarters
BOSTON, MA
Listed Since
May 6, 2022
Website
PEPG Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
PEPG Volatility
PepGen Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
